查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1320232

癌症幹細胞市場:各癌症形態，各用途，各國，各地區- 產業分析，市場規模，市場佔有率，2023-2030年預測

Cancer Stem Cells Market with COVID-19 Impact Analysis, By Cancer Forms, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 359 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年癌症幹細胞市場規模為 10.567 億美元，2023 年至 2030 年複合年增長率將達到 9.1%

癌症幹細胞市場 - 市場動態：

癌症疾病盛行率的增加和幹細胞研究投資的增加預計將推動對癌症幹細胞的需求。

癌症幹細胞市場受到全球癌症發生率上升的顯著影響。隨著癌症仍然是全世界死亡的主要原因，使用癌症幹細胞的研究和治療變得越來越重要。對幹細胞研究（特別是癌症幹細胞）的資金和投資的增加正在加速新發現和創新療法的創造。非營利基金會、營利公司和政府機構都為這一擴張做出了貢獻。基因組學、分子生物學和免疫治療領域的進步提高了對癌症幹細胞及其在腫瘤發生和進展中的功能的理解。

製藥公司資助臨床試驗和癌症幹細胞研究，以開發專門針對癌症幹細胞的新療法。如果臨床試驗的結果是正面的，這將刺激市場擴張。臨床試驗對於確認潛在藥物的安全性和有效性至關重要。

癌症幹細胞市場 - 主要見解：

  • 由於對動物健康和營養的日益關注，癌症幹細胞產業預計將大幅成長。
  • 從應用來看，標靶癌症幹細胞區隔市場預計將在 2022 年展現最大的市場佔有率。
  • 根據癌症形態，乳癌區隔市場在 2022 年處於領先地位。
  • 按地區劃分，北美將在 2022 年實現銷售領先。

癌症幹細胞市場 - 區隔分析：

全球癌症幹細胞市場根據癌症形態、應用、系統和區域進行區隔。

依癌症的形態，癌症分為七種：乳癌、血癌、腦瘤、肺癌、胰臟癌、膀胱癌和其他癌症。

市場依應用分為兩類：標靶癌症幹細胞和基於幹細胞的癌症治療。靶向癌症幹細胞領域主導市場。小型幹細胞的日益普及預計將支持市場成長。

癌症幹細胞市場 - 地理洞察：

從地理上看，本報告涵蓋北美、拉丁美洲、歐洲、亞太地區和中東非洲。這些地區根據其經營所在的國家進一步劃分。

癌症幹細胞市場 - 競爭格局：

醫療保健和基因工程的不斷進步正在影響癌症幹細胞市場。醫療機構（包括應用程式提供者）在多種因素上競爭，包括癌症治療、聲譽和可用性。企業進入市場和擴大市場佔有率的主要方法和策略包括新產品發布、研發支出、分銷網絡開發和併購。以下介紹一些最近的趨勢。

最近動態

2022 年 6 月，BlueRock Therapeutics 在德國引進了一個新的細胞治療設施，以加強其在歐洲的臨床能力。

調查的主要特徵

  • 本研究報告提供了癌症幹細胞市場的市場規模、複合年增長率 (CAGR%) 以及以 2022 年為基準年的估計和預測（2023-2030 年）。
  • 這份研究報告為客戶提供了有關癌症幹細胞市場最新趨勢的見解。
  • 研究報告闡明了不同區隔市場/國家的潛在成長機會，並解釋了癌症幹細胞市場有吸引力的投資主張矩陣。
  • 確定癌症幹細胞市場的新投資機會、現有公司面臨的挑戰以及永續成長因素。
  • 研究範圍中詳細討論了癌症幹細胞市場規模、預測、複合年增長率以及 COVID-19 對市場動態的影響，也涵蓋了對 COVID-19 後癌症幹細胞市場的詳細見解。
  • 為了向本報告的使用者提供對癌症幹細胞市場的全面了解，本報告也對癌症幹細胞市場的競爭格局和關鍵創新者進行了分析。
  • 本報告包??含一份成長前景圖分析，根據市場規模、成長率和吸引力對所有產業領域進行基準測試。
  • 本報告提供了主要市場參與者的詳細公司概況，幫助您了解癌症幹細胞市場中營運公司的財務狀況和策略舉措。
  • 此外，該報告還揭示了全球和區域市場主要參與者的重要收購和併購、聯盟和合資企業、新產品發布、研發以及區域擴張。
  • 全球癌症幹細胞市場報告主要針對該行業的各個利益相關者，例如供應商、投資者、新進業者、分銷商和財務分析師。

目錄

第1章 癌症幹細胞市場概要

  • 調查範圍

第2章 摘要整理

  • 市場明細
  • 競爭考察

第3章 癌症幹細胞主要的市場趨勢

  • 癌症幹細胞推動市場要素
  • 癌症幹細胞阻礙市場要素
  • 癌症幹細胞市場機會
  • 癌症幹細胞市場未來趨勢

第4章 癌症幹細胞產業調查

  • PEST分析
  • 波特的五力分析
  • 成長預測的製圖
  • 法規結構的分析

第5章 癌症幹細胞市場:COVID-19影響分析

  • 新型冠狀病毒感染疾病前的影響分析
  • 新型冠狀病毒感染疾病後的影響分析

第6章 癌症幹細胞市場形勢

  • 癌症幹細胞市場佔有率分析，2022年
  • 各主要製造商的明細資料
    • 確立的企業的分析
    • 新興企業的分析

第7章 癌症幹細胞市場- 各癌症形態

  • 概要
    • 各癌症形態市場區隔佔有率分析
    • 胸
    • 血
    • 腦
    • 肺
    • 胰臟
    • 膀胱
    • 其他

第8章 癌症幹細胞市場- 各用途

  • 概要
    • 各用途市場區隔佔有率分析
    • 標的癌症性幹細胞
    • 幹細胞為基礎癌症治療

第9章 癌症幹細胞市場-各地區

  • 簡介
  • 北美
    • 概要
    • 癌症幹細胞的北美的主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概要
    • 癌症幹細胞的歐洲的主要製造商
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區(APAC)
    • 概要
    • 亞太地區的癌症幹細胞的主要製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 概要
    • 癌症幹細胞南美的主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概要
    • 中東及非洲的癌症幹細胞的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第10章 主要供應商分析- 癌症幹細胞產業

  • 競爭儀表板
  • 企業簡介
    • Thermo Fisher Scientific, Inc.
    • AbbVie, Inc.
    • Merck KGaA
    • Bionomics
    • Lonza
    • Stemline Therapeutics, Inc.
    • Miltenyi Biotec
    • PromoCell GmbH
    • MacroGenics, Inc
    • OncoMed Pharmaceuticals, Inc.
    • Irvine Scientific
    • STEMCELL Technologies Inc.
    • BlueRock Therapeutics
    • Sino Biological Inc.
    • Biotime Inc.

第11章 分析師的全方位展望

Product Code: ANV1543

REPORT HIGHLIGHT

Cancer Stem Cells Market size was valued at USD 1,056.7 Million in 2022, expanding at a CAGR of 9.1% from 2023 to 2030.

A subgroup of cells having stem cell-like characteristics that are present in tumors are known as cancer stem cells. They have the same capacity for self-renewal and cell cancer forms differentiation as regular stem cells. However, cancer stem cells are tumorigenic, meaning they can give rise to new cancer cells and aid in the spread of disease, in contrast to normal stem cells.

Cancer Stem Cells Market- Market Dynamics:

Growing prevalence of cancer diseases and rising investment in stem cell research is expected to propel the cancer stem cells demand.

The market for cancer stem cells has been significantly influenced by the rising incidence of cancer across the world. Research and treatments involving cancer stem cells are becoming more important as cancer continues to be the leading cause of death worldwide. The rate of new discoveries and the creation of innovative therapies has accelerated due to increased financing and investment in stem cell research, especially cancer stem cells. Nonprofit foundations, for-profit businesses, and government agencies have all contributed to this expansion. Understanding cancer stem cells and their function in tumor initiation and progression has improved because of developments in the fields of genomics, molecular biology, and immunotherapy.

Pharmaceutical corporations are funding clinical trials and research into cancer stem cells to create novel treatments that specifically target these cells. Positive trial outcomes can spur market expansion. Clinical studies are crucial for confirming the security and effectiveness of prospective medicines.

Cancer Stem Cells Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cancer Stem Cells market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2023-2030)
  • The Cancer Stem Cells industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
  • Based on Application, targeted cancerous stem cells segment was predicted to show maximum market share in the year 2022.
  • Based on Cancer Forms, segmentation, breast cancer segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Cancer Stem Cells Market- Segmentation Analysis:

The Global Cancer Stem Cells Market is segmented on the basis of Cancer Forms, Application, System, and Region.

The market is divided into seven categories based on Cancer Forms: breast, blood, brain, lung, pancreatic, bladder, and others. The rocket launchers segment dominates the market. Increasing demand rocket launching system is contributing to market growth.

The market is divided into two categories based on Application: targeted cancerous stem cells, and stem-cell based cancer therapy. The targeted cancerous stem cells segment dominates the market. Growing prevalence of small stem cells is expected to boost the market growth.

Cancer Stem Cells Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Cancer Stem Cells Market- Competitive Landscape:

Owing to the increasing advancement in healthcare and genetic engineering, which influence the Cancer Stem Cells market. Healthcare facilities including application providers compete on various factors, such as cancer therapy, reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In June 2022, BlueRock Therapeutics has introduced new cell treatment site in Germany to enhance its clinical capabilities in Europe.

Key features of the study:

  • This proposed research study on Cancer Stem Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cancer Stem Cells market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Stem Cells market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Stem Cells market
  • Impact of COVID-19 on Cancer Stem Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Stem Cells market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cancer Stem Cells market, we have also included competitive landscape and key innovator analysis for the Cancer Stem Cells market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Cancer Stem Cells market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cancer Stem Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER STEM CELLS MARKET KEY PLAYERS

  • Thermo Fisher Scientific, Inc.
  • AbbVie, Inc.
  • Merck KGaA
  • Bionomics
  • Lonza
  • Stemline Therapeutics, Inc.
  • Miltenyi Biotec
  • PromoCell GmbH
  • MacroGenics, Inc
  • OncoMed Pharmaceuticals, Inc.
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • BlueRock Therapeutics
  • Sino Biological Inc.
  • Biotime Inc.

GLOBAL CANCER STEM CELLS MARKET, BY CANCER FORMS

  • Breast
  • Blood
  • Brain
  • Lung
  • Pancreatic
  • Bladder
  • Others

GLOBAL CANCER STEM CELLS MARKET, BY APPLICATION

  • Targeted Cancerous Stem Cells
  • Stem-cell based Cancer Therapy

GLOBAL CANCER STEM CELLS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Stem Cells Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Stem Cells Market Snippet by Cancer Forms
    • 2.1.2. Cancer Stem Cells Market Snippet by Application
    • 2.1.3. Cancer Stem Cells Market Snippet by Country
    • 2.1.4. Cancer Stem Cells Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Stem Cells Key Market Trends

  • 3.1. Cancer Stem Cells Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Stem Cells Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Stem Cells Market Opportunities
  • 3.4. Cancer Stem Cells Market Future Trends

4. Cancer Stem Cells Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Stem Cells Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Stem Cells Market Landscape

  • 6.1. Cancer Stem Cells Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Stem Cells Market - By Cancer Forms

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Cancer Forms, 2022 & 2030 (%)
    • 7.1.2. Breast
    • 7.1.3. Blood
    • 7.1.4. Brain
    • 7.1.5. Lung
    • 7.1.6. Pancreatic
    • 7.1.7. Bladder
    • 7.1.8. Others

8. Cancer Stem Cells Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 8.1.2. Targeted Cancerous Stem Cells
    • 8.1.3. Stem-cell based Cancer Therapy

9. Cancer Stem Cells Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Cancer Stem Cells Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.6.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.7.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Cancer Stem Cells Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.10.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.11.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.12.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.13.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.14.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Cancer Stem Cells Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. India Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. China Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. South Korea Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Australia
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Australia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Thailand
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Thailand Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Indonesia
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Indonesia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Philippines
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Philippines Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.15. Rest of APAC
      • 9.4.15.1. Overview
      • 9.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.15.3. Rest of APAC Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Cancer Stem Cells Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Brazil Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Mexico Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Argentina Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Colombia
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Colombia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.11. Rest of LATAM
      • 9.5.11.1. Overview
      • 9.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.11.3. Rest of LATAM Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Cancer Stem Cells Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. Saudi Arabia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. United Arab Emirates Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Israel
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Israel Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Turkey
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Turkey Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Algeria
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Algeria Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Egypt
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Egypt Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.13. Rest of MEA
      • 9.6.13.1. Overview
      • 9.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.13.3. Rest of MEA Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Cancer Stem Cells Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific, Inc.
    • 10.2.2. AbbVie, Inc.
    • 10.2.3. Merck KGaA
    • 10.2.4. Bionomics
    • 10.2.5. Lonza
    • 10.2.6. Stemline Therapeutics, Inc.
    • 10.2.7. Miltenyi Biotec
    • 10.2.8. PromoCell GmbH
    • 10.2.9. MacroGenics, Inc
    • 10.2.10. OncoMed Pharmaceuticals, Inc.
    • 10.2.11. Irvine Scientific
    • 10.2.12. STEMCELL Technologies Inc.
    • 10.2.13. BlueRock Therapeutics
    • 10.2.14. Sino Biological Inc.
    • 10.2.15. Biotime Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Stem Cells Market: Cancer Forms Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Forms
  • TABLE Global Cancer Stem Cells Market, by Cancer Forms 2018-2030 (USD Million)
  • TABLE Cancer Stem Cells Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Cancer Stem Cells Market, by Product 2018-2030 (USD Million)
  • TABLE Cancer Stem Cells Market: Regional snapshot (2022)
  • TABLE Cancer Stem Cells Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Stem Cells Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Stem Cells Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cancer Stem Cells Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Cancer Forms segment market share analysis, 2022 & 2030
  • FIGURE Cancer Forms segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Europe Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Asia Pacific Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Latin America Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Middle East and Africa Cancer Stem Cells Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Germany Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE India Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Brazil Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)